glp 1 approved for sleep apnea Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes Therapeutic Potential of Glucagon-like Peptide-1

J Am Soc Nephrology: JASN

64.Liu, J

For decades, the GLP-1 receptor was classified as a target that could only be meaningfully activated by peptide ligands

So what about triple agonists (GIP/GLP-1/Glucagon) Let us introduce you to @LillyPad latest exciting molecule LY3437943 aka "Triple G"

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work

Part of our responsibility to the millions of customers who trust us with their healthcare is to understand the scale of the challenges they face and use our platform to combat them. Branded GLP-1 medications are challenging to access across the country, with availability fluctuating up and down as drugmakers invest in their ability to meet the immense amount of demand